Skip to content

Company information lookup

ANTISENSE THERAPEUTICS LIMITED (ANP)

The development of novel antisense pharmaceuticals for commercially important human conditions.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
ANP 0.140 7.69% 0.140 0.145 0.135 0.145 0.135 353,879
(Status - RE)

ANTISENSE THERAPEUTICS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code ANP
Securities
Official Listing Date 20 December, 2001
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.antisense.com.au/
Registered Office Address 6 - 8 Wallace Avenue, TOORAK, VIC, AUSTRALIA, 3142
Head Office Telephone (03) 9827 8999
Head Office Fax (03) 9827 1166
Share Registry BOARDROOM PTY LIMITED
LEVEL 7, 207 KENT STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone (02) 9290 9600
Directors / Senior Management
Mr Robert Moses (Chairman)
Mr Mark Diamond (Managing Director, CEO)
Mr Chris Belyea (Non Exec. Director)
Prof. Graham Mitchell (Non Exec. Director)
Mr Phillip Hains (CFO)
Mr Simon Watkin (Investor Relations)
Company Secretary Mr Phillip Hains
Principal Activities The development of novel antisense pharmaceuticals for commercially important human conditions.

ANTISENSE THERAPEUTICS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
22/09/2014 asterix ATL1102 Phase II MS trial results published in NEUROLOGY 2 PDF
16/09/2014 asterix ATL1102 for MS further development plans 2 PDF
09/09/2014   BRR Interview - CEO Discusses ATL1103 Phase II Trial Results 2 PDF
04/09/2014   Ceasing to be a substantial holder 1 PDF
03/09/2014 asterix ATL1103 Phase II Trial - Successful Efficacy Results 7 PDF
01/09/2014 asterix Trading Halt 2 PDF
28/08/2014   ATL1103 Acromegaly Phase II Trial Results 2 PDF
25/08/2014 asterix Appendix 4E and Full Year Audited Statutory Accounts 81 PDF
19/08/2014 asterix Strategy Update - ATL1103 & ATL1102 2 PDF
31/07/2014 asterix Appendix 4C - quarterly 6 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
19 Sep 2014 0.130 -3.7% 0.135 0.130 178,668
18 Sep 2014 0.135 0% 0.135 0.135 58,000
17 Sep 2014 0.135 -3.57% 0.145 0.135 144,902
16 Sep 2014 0.140 0% 0.145 0.140 141,986
15 Sep 2014 0.140 3.7% 0.140 0.135 240,111

* Volume of shares shown represents only those shares traded on ASX.

ANTISENSE THERAPEUTICS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security ANP. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security ANP

Warrants & Structured Products

No warrants & Structured Products are available over the security ANP

ASX CFDs

No Contracts For Differences are available over the security ANP